Benralizumab: a unique IL-5 inhibitor for severe asthma

References

• BarnettSBNurmagambetovTACosts of asthma in the United States: 2002–2007J Allergy Clin Immunol2011127114515221211649
   PubMed Web of Science ®Google Scholar
• WoolcockAJSteroid resistant asthma: what is the clinical definition?Eur Respir J1993657437478519386
   PubMed Web of Science ®Google Scholar
• ChanMTLeungDYSzeflerSJSpahnJDDifficult-to-control asthma: clinical characteristics of steroid-insensitive asthmaJ Allergy Clin Immunol199810155946019600494
   PubMed Web of Science ®Google Scholar
• WoodruffPGModrekBChoyDFT-helper type 2-driven inflammation defines major subphenotypes of asthmaAm J Respir Crit Care Med2009180538839519483109
   PubMed Web of Science ®Google Scholar
• MooreWCMeyersDAWenzelSEIdentification of asthma phenotypes using cluster analysis in the Severe Asthma Research ProgramAm J Respir Crit Care Med2010181431532319892860
   PubMed Web of Science ®Google Scholar
• BusseWWAsthma diagnosis and treatment: filling in the information gapsJ Allergy Clin Immunol2011128474075021875745
   PubMed Web of Science ®Google Scholar
• DweikRABoggsPBErzurumSCAn official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applicationsAm J Respir Crit Care Med2011184560261521885636
   PubMed Web of Science ®Google Scholar
• MartinRJSzeflerSJKingTSThe predicting response to inhaled corticosteroid efficacy (PRICE) trialJ Allergy Clin Immunol20071191738017208587
   PubMed Web of Science ®Google Scholar
• National Heart Lung, and Blood InstituteNational asthma education and prevention program, third expert panel on the diagnosis and management of asthmaExpert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma2007 Available from http://www.ncbi.nlm.nih.gov/books/NBK7222/Accessed August 2007
   Google Scholar
• DenningDWO’DriscollBRPowellGRandomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: the Fungal Asthma Sensitization Trial (FAST) studyAm J Respir Crit Care Med20091791111818948425
   PubMed Web of Science ®Google Scholar
• BatemanEDIzquierdoJLHarnestUEfficacy and safety of roflumilast in the treatment of asthmaAnn Allergy Asthma Immunol200696567968616729780
   PubMed Web of Science ®Google Scholar
• KistemakerLEHiemstraPSBosISTiotropium attenuates IL-13-induced goblet cell metaplasia of human airway epithelial cellsThorax201570766867625995156
   PubMed Web of Science ®Google Scholar
• DunnRMWechslerMEAnti-interleukin therapy in asthmaClin Pharmacol Ther2015971556525670383
   PubMed Web of Science ®Google Scholar
• BusseWWMorganWJGergenPJRandomized trial of omalizumab (anti-IgE) for asthma in inner-city childrenN Engl J Med2011364111005101521410369
   PubMed Web of Science ®Google Scholar
• StrunkRCBloombergGROmalizumab for asthmaN Engl J Med2006354252689269516790701
   PubMed Web of Science ®Google Scholar
• FahyJVEosinophilic and neutrophilic inflammation in asthma: insights from clinical studiesProc Am Thorac Soc20096325625919387026
   PubMedGoogle Scholar
• WoodruffPGKhashayarRLazarusSCRelationship between airway inflammation, hyperresponsiveness, and obstruction in asthmaJ Allergy Clin Immunol2001108575375811692100
   PubMed Web of Science ®Google Scholar
• LouisRLauLCBronAORoldaanACRadermeckerMDjukanovicRThe relationship between airways inflammation and asthma severityAm J Respir Crit Care Med2000161191610619791
   PubMed Web of Science ®Google Scholar
• HornBRRobinEDTheodoreJVan KesselATotal eosinophil counts in the management of bronchial asthmaN Engl J Med197529222115211551124105
   PubMed Web of Science ®Google Scholar
• JansonCHeralaMBlood eosinophil count as risk factor for relapse in acute asthmaRespir Med19928621011041615173
   PubMed Web of Science ®Google Scholar
• TaylorKJLukszaARPeripheral blood eosinophil counts and bronchial responsivenessThorax19874264524563660304
   PubMed Web of Science ®Google Scholar
• DjukanovicRRocheWRWilsonJWMucosal inflammation in asthmaAm Rev Respir Dis199014224344572200318
   PubMed Web of Science ®Google Scholar
• CastroMZangrilliJWechslerMEReslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trialsLancet Respir Med20153535536625736990
   PubMed Web of Science ®Google Scholar
• AyarsGHAltmanLCGleichGJLoegeringDABakerCBEosinophil-and eosinophil granule-mediated pneumocyte injuryJ Allergy Clin Immunol19857645956044056248
   PubMed Web of Science ®Google Scholar
• GleichGJThe eosinophil and bronchial asthma: current understandingJ Allergy Clin Immunol19908524224362406322
   PubMed Web of Science ®Google Scholar
• ShawRJWalshGMCromwellOMoqbelRSpryCJKayABActivated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulationNature198531660241501524010786
   PubMed Web of Science ®Google Scholar
• GundelRHLettsLGGleichGJHuman eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primatesJ Clin Invest1991874147014732010556
   PubMed Web of Science ®Google Scholar
• CoyleAJAckermanSJBurchRProudDIrvinCGHuman eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generationJ Clin Invest1995954173517407706481
   PubMed Web of Science ®Google Scholar
• BousquetJChanezPLacosteJYEosinophilic inflammation in asthmaN Engl J Med199032315103310392215562
   PubMed Web of Science ®Google Scholar
• DenteFLBacciEBartoliMLMagnitude of late asthmatic response to allergen in relation to baseline and allergen-induced sputum eosinophilia in mild asthmatic patientsAnn Allergy Asthma Immunol2008100545746218517078
   PubMed Web of Science ®Google Scholar
• BrownTFDA panel backs mepolizumab for severe eosinophilic asthmaMedscape Medical News6112015
   Google Scholar
• GreenRHBrightlingCEMcKennaSAsthma exacerbations and sputum eosinophil counts: a randomised controlled trialLancet200236093471715172112480423
   PubMed Web of Science ®Google Scholar
• JayaramLPizzichiniMMCookRJDetermining asthma treatment by monitoring sputum cell counts: effect on exacerbationsEur Respir J200627348349416507847
   PubMed Web of Science ®Google Scholar
• ChlumskyJStrizITerlMVondracekJStrategy aimed at reduction of sputum eosinophils decreases exacerbation rate in patients with asthmaJ Int Med Res200634212913916749408
   PubMed Web of Science ®Google Scholar
• SilkoffPELentAMBusackerAAExhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthmaJ Allergy Clin Immunol200511661249125516337453
   PubMed Web of Science ®Google Scholar
• LederleFAPluharREJosephAMNiewoehnerDETapering of corticosteroid therapy following exacerbation of asthma. A randomized, double-blind, placebo-controlled trialArch Intern Med198714712220122033318751
   PubMedGoogle Scholar
• RestrepoRDPetersJNear-fatal asthma: recognition and managementCurr Opin Pulm Med2008141132318043271
   PubMed Web of Science ®Google Scholar
• Bellido-CasadoJPlazaVPerpinaMInflammatory response of rapid onset asthma exacerbationArch Bronconeumol20104611587593 Spanish20832159
   PubMed Web of Science ®Google Scholar
• PavordIDHaldarPBraddingPWardlawAJMepolizumab in refractory eosinophilic asthmaThorax201065437020388767
   PubMed Web of Science ®Google Scholar
• TakatsuKTakakiSHitoshiYInterleukin-5 and its receptor system: implications in the immune system and inflammationAdv Immunol1994571451907872157
   PubMed Web of Science ®Google Scholar
• RothenbergMEHoganSPThe eosinophilAnn Rev Immunol20062414717416551246
   PubMed Web of Science ®Google Scholar
• KolbeckRKozhichAKoikeMMEDI-563, a humanized anti-IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity functionJ Allergy Clin Immunol2010125613441353.e134220513525
   PubMed Web of Science ®Google Scholar
• GuoCBLiuMCGalliSJBochnerBSKagey-SobotkaALichtensteinLMIdentification of IgE-bearing cells in the late-phase response to antigen in the lung as basophilsAm J Respir Cell Mol Biol19941043843907510984
   PubMed Web of Science ®Google Scholar
• GauvreauGMLeeJMWatsonRMIraniAMSchwartzLBO’ByrnePMIncreased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmaticsAm J Respir Crit Care Med200016151473147810806141
   PubMed Web of Science ®Google Scholar
• KauffmannFNeukirchFAnnesiIKorobaeffMDoreMFLellouchJRelation of perceived nasal and bronchial hyperresponsiveness to FEV1, basophil counts, and methacholine responseThorax19884364564613420556
   PubMed Web of Science ®Google Scholar
• KimuraIMoritaniYTanizakiYBasophils in bronchial asthma with reference to reagin-type allergyClin Allergy1973321952024131253
   PubMedGoogle Scholar
• MaruyamaNTamuraGAizawaTAccumulation of basophils and their chemotactic activity in the airways during natural airway narrowing in asthmatic individualsAm J Respir Crit Care Med19941504108610937921441
   PubMed Web of Science ®Google Scholar
• KoshinoTTeshimaSFukushimaNIdentification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthmaClin Exp Allergy1993231191992510779279
   PubMed Web of Science ®Google Scholar
• KepleyCLMcFeeleyPJOliverJMLipscombMFImmunohistochemical detection of human basophils in postmortem cases of fatal asthmaAm J Respir Crit Care Med200116461053105811587996
   PubMed Web of Science ®Google Scholar
• NairPPizzichiniMMKjarsgaardMMepolizumab for prednisone-dependent asthma with sputum eosinophiliaN Engl J Med20093601098599319264687
   PubMed Web of Science ®Google Scholar
• CastroMMathurSHargreaveFReslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled studyAm J Respir Crit Care Med2011184101125113221852542
   PubMed Web of Science ®Google Scholar
• Flood-PagePTMenzies-GowANKayABRobinsonDSEosinophil’s role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airwayAm J Respir Crit Care Med2003167219920412406833
   PubMed Web of Science ®Google Scholar
• BelEHWenzelSEThompsonPJOral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthmaN Engl J Med2014371131189119725199060
   PubMed Web of Science ®Google Scholar
• OrtegaHGLiuMCPavordIDMepolizumab treatment in patients with severe eosinophilic asthmaN Engl J Med2014371131198120725199059
   PubMed Web of Science ®Google Scholar
• PavordIDKornSHowarthPMepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialLancet2012380984265165922901886
   PubMed Web of Science ®Google Scholar
• HaldarPBrightlingCEHargadonBMepolizumab and exacerbations of refractory eosinophilic asthmaN Engl J Med20093601097398419264686
   PubMed Web of Science ®Google Scholar
• CastroMWenzelSEBleeckerERBenralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging studyLancet Respir Med201421187989025306557
   PubMed Web of Science ®Google Scholar
• BusseWWKatialRGossageDSafety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of subjects with mild asthmaJ Allergy Clin Immunol2010125612371244.e220513521
   PubMed Web of Science ®Google Scholar
• GhaziATrikhaACalhounWJBenralizumab – a humanized mAb to IL-5Rα with enhanced antibody-dependent cell-mediated cytotoxicity – a novel approach for the treatment of asthmaExpert Opin Biol Ther201212111311822136436
   PubMed Web of Science ®Google Scholar
• WalshGMEosinophil apoptosis and clearance in asthmaJ Cell Death20136172525278777
   PubMedGoogle Scholar
• IidaSMisakaHInoueMNonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIaClin Cancer Res20061292879288716675584
   PubMed Web of Science ®Google Scholar
• LavioletteMGossageDLGauvreauGEffects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophiliaJ Allergy Clin Immunol2013132510861096.e523866823
   PubMed Web of Science ®Google Scholar
• NowakRMParkerJMSilvermanRAA randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthmaAm J Emerg Med2015331142025445859
   PubMed Web of Science ®Google Scholar
• RoweBHSpoonerCHDucharmeFMBretzlaffJABotaGWCorticosteroids for preventing relapse following acute exacerbations of asthmaCochrane Database Syst Rev2007183CD00019517636617
   PubMed Web of Science ®Google Scholar
• MiravitllesMAlcazarBAlvarezFJWhat pulmonologists think about the asthma-COPD overlap syndromeInt J Chron Obstruct Pulmon Dis2015101321133026270415
   PubMed Web of Science ®Google Scholar
• BujarskiSParulekarADSharafkhanehAHananiaNAThe asthma COPD overlap syndrome (ACOS)Curr Allergy Asthma Rep201515350925712010
   PubMed Web of Science ®Google Scholar
• LouieSZekiAASchivoMThe asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerationsExpert Rev Clin Pharmacol20136219721923473596
   PubMed Web of Science ®Google Scholar
• PostmaDSRabeKFThe asthma-COPD overlap syndromeN Engl J Med2015373131241124926398072
   PubMed Web of Science ®Google Scholar
• BrightlingCEBleeckerERPanettieriRAJrBenralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a studyLancet Respir Med201421189190125208464
   PubMed Web of Science ®Google Scholar
• SoterSBartaIAntusBPredicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxideInflammation20133651178118523681903
   PubMed Web of Science ®Google Scholar
• ValentPKlionADHornyHPContemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromesJ Allergy Clin Immunol20121303607612.e922460074
   PubMed Web of Science ®Google Scholar
• ThamrinCTaylorDRJonesSLSukiBFreyUVariability of lung function predicts loss of asthma control following withdrawal of inhaled corticosteroid treatmentThorax201065540340820435861
   PubMed Web of Science ®Google Scholar